Meanwhile, in addition to EOC, results showed that a significant reduction in disease free survival only in patients with pancreatic adenocarcinoma (PAAD) with low GPR12 mRNA expression than those with high GPR12 mRNA expression (Supplementary Figure 2B). The gene discussed is GPR12; the disease is pancreatic adenocarcinoma.